OP24 A novel subcutaneous infliximab (CT-P13): 1-year...

Journal of Crohn's and Colitis 2020 / 01 Vol. 14; Iss. Supplement

OP24 A novel subcutaneous infliximab (CT-P13): 1-year results including switching results from intravenous infliximab (CT-P13) in patients with active Crohn’s disease and ulcerative colitis

Ben-Horin, S, Leszczyszyn, J, Dudkowiak, R, Lahat, A, Gawdis-Wojnarska, B, Pukitis, A, Horynski, M, Farkas, K, Kierkus, J, Kowalski, M, Ye, B D, Reinisch, W, Lee, S J, Kim, S H, Kim, M R, Kim, Y A, Ki
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjz203.023
Date:
January, 2020
File:
PDF, 1.38 MB
2020
Conversion to is in progress
Conversion to is failed